Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Reduced Prophylactic Nodal Irradiation in Chemoradiotherapy for HPV-Related Oropharyngeal Cancer
jRCT1042250121Recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin in oropharyngeal cancer, sponsored by Japan Society for the Promotion of Science. Primary endpoint: 2-year locoregional control rate. Started Oct 2025; status: recruiting.
02
Drugs
cisplatin
03
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on jRCT1042250121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1042250121.